Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872830 | 0.90 | LMNA (0.58) | TDP1ALDH1A1HPGDKMT2ANPC1 | |
| SCHEMBL5907642 | 0.88 | TDP1 (0.56) | TDP1ALOX5APPHCAR2ALDH1A1 | |
| SCHEMBL6050179 | 0.88 | TDP1 (0.56) | TDP1ALOX5APPHCAR2ALDH1A1 | |
| SCHEMBL30136419 | 0.87 | TDP1 (0.45) | TDP1ALOX5APPHCAR2ALDH1A1 | |
| SCHEMBL16673203 | 0.85 | TDP1 (0.53) | TDP1ALOX5APPHCAR2ALDH1A1 | |
| SCHEMBL16672669 | 0.85 | MET (0.48) | TDP1ALOX5APPALDH1A1HPGD | |
| SCHEMBL4956181 | 0.83 | TDP1 (0.64) | TDP1ALOX5APPHCAR2ALDH1A1 | |
| SCHEMBL28505436 | 0.83 | TDP1 (0.58) | TDP1ALOX5APPHCAR2ALDH1A1 | |
| SCHEMBL14298964 | 0.83 | THRB (0.54) | TDP1ALDH1A1HPGDKMT2ANPC1 | |
| SCHEMBL111390 | 0.82 | ALDH1A1 (0.61) | TDP1HCAR2ALDH1A1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12568998-B2 | Flavouring composition with balanced taste profile | SYMRISE AG (DE) | 2026-03-10 | — | — | US | claimed |
| US-12514798-B2 | Use of [6]-paradol for stabilization of cosmetic compositions | SYMRISE AG (DE) | 2026-01-06 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| EP-4444108-B1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| EP-4565194-A1 | ODOR AND COLORANT STABILIZED COMPOSITIONS | Symrise AG (DE) | 2025-06-11 | — | — | EP | claimed |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | claimed |
| CN-119924491-A | Flavoring composition with balanced taste characteristics | 西姆莱斯有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119744164-A | Odor and colorant stable compositions | 西姆莱斯股份公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2025026525-A1 | HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS | SYMRISE AG (DE) | 2025-02-06 | — | — | WO | claimed |
| US-20250040580-A1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-02-06 | — | — | US | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| CN-1572335-A | Self-Service respiratory vaccination instrument for SARS infectious disease | CONG FANZI (CN) | 2005-02-02 | — | — | CN | claimed |
| CN-1520846-A | Quick-effective aerosol with plant aroma and its preparation | 丛繁滋 | 2004-08-18 | — | — | CN | claimed |
| CN-1500477-A | Quick result aerosol with plant aroma and its preparation | 丛繁滋 | 2004-06-02 | — | — | CN | claimed |
| CN-1475204-A | Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method | 丛繁滋 | 2004-02-18 | — | — | CN | claimed |
| US-6322838-B1 | Mint and/or fruit flavor compositions | HAARMANN & REIMER GMBH (DE) | 2001-11-27 | — | — | US | claimed |
| CN-1226589-A | Preparation of mono-component anaerobic adhesive for fastening screws and sealing flat surfaces | LIANG YIXUN (CN) | 1999-08-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12568998-B2 | Flavouring composition with balanced taste profile | TAS2R20, TAS2R50, TAS2R40 | TDP1 2902/4885ALOX5 3817/4885APP 1120/4885 |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | TDP1 3632/4885ALOX5 356/4885APP 505/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | TDP1 3581/4885ALOX5 340/4885APP 717/4885 |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | TTR, TAS2R5, TAS2R50 | TDP1 1687/4885ALOX5 1209/4885APP 4299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.